QA: Dynavax Technologies CORP in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2019_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 174,364,000
1 IntangibleAssetsNetIncludingGoodwill 13,861,000
2 PropertyPlantAndEquipmentNet 17,064,000
3 remainder_Assets 5,595,000
4 LiabilitiesCurrent 38,033,000
5 LiabilitiesNoncurrent 109,786,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 54,783,369
9 ResearchAndDevelopmentExpense 74,649,867
10 remainder_Expenses 166,752,967
11 remainder_Revenues 5,090,432
12 remainder_NetIncome 5,428,285
13 remainder_ComprehensiveNetIncome 824,797
  yvar yval
0 Assets 210,884,000
1 Liabilities 147,819,000
2 Expenses 296,186,203
3 Revenues 5,090,432
4 StockholdersEquity 63,065,000
5 NetIncome -285,667,486
6 ComprehensiveNetIncome -285,255,088
7 BaseVar 333,116,358
8 EconomicCapitalRatiobeforeLimitedLiability -0.824
9 EconomicCapitalRatio 1.34

Edgar->Model Mapping

Feature Distribution

Change over Time